Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kristy Stanfield

Physician Assistant Stony Brook, NY Physician Assistant

NPI 1588817688 CMS profile 10827959

Stony Brook University Medical Ctr, Dept Of Surgery, Hsc T19-090, Stony Brook, NY 11794

Open in the dashboard

General payments

$5,095

83 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kristy Stanfield of Stony Brook, NY is reported in the CMS Open Payments database as having received $5,095 across 83 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $322 5
2024 General $433 11
2023 General $402 17
2022 General $2,887 22
2021 General $1,050 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kristy Stanfield
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Kristy Stanfield were reported at $322. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Kristy Stanfield Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,050 $132 $37–$438 $132
2022 $2,887 $155 $48–$522 $149
2023 $402 $167 $52–$557 $160
2024 $433 $178 $55–$600 $164
2025 $322 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $2,410 5 payments
  2. Tactile Systems Technology Inc $1,916 51 payments
  3. Janssen Pharmaceuticals, Inc $406 16 payments
  4. Bolton Medical Inc $136 1 payment
  5. Terumo Medical Corporation $81 3 payments
  6. Boston Scientific Corporation $40 1 payment
  7. Organogenesis Inc. $21 1 payment
  8. Bard Peripheral Vascular, Inc. $21 1 payment
  9. Smith+Nephew, Inc. $20 1 payment
  10. Advanced Oxygen Therapy Inc. $16 1 payment
  11. Other $27 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,844 80 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,200 1 payment
  3. Travel and Lodging $1,050 2 payments
Products named General payments · program years 2021–2025
  1. VENASEAL $2,266 4 payments
  2. Flexitouch Plus $1,916 51 payments
  3. entre $1,049 25 payments
  4. Entre Plus $729 23 payments
  5. XARELTO $406 16 payments
  6. ENDURANT IIS $143 1 payment
  7. Nimbl $139 3 payments
  8. Relay Grafts $136 1 payment
  9. Azur CX Detachable $58 2 payments
  10. Varithena Administration Pack $40 1 payment
  11. Other $158 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

44

Median for Physician Assistant: 241

Drug cost

$26,851

Median for Physician Assistant: $4,110

Branded share of claims

100%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xarelto Rivaroxaban Brand 11 $13,515
Eliquis Apixaban Brand 15 $13,239
Clopidogrel Clopidogrel Bisulfate Brand 18 $98

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$4,276

Medicare's payments for the services billed

Medicare patients

44

Average age 75

Services billed

46

27 women, 17 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 66%
Ischemic heart disease 41%
Diabetes 34%
Atrial fibrillation 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

83 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record